Significance of expression of COX-2 and GCS in gastric cancer

Jun-Xian Wang,Kai-Guang Zhang,Xiang-Chun Li,Xiao-Qiu Wang,Min Ding
DOI: https://doi.org/10.11569/wcjd.v19.i20.2171
2011-01-01
World Chinese Journal of Digestology
Abstract:AIM: To investigate the expression of cyclooxygenase-2 (COX-2) and glucosylceramide synthase (GCS) in gastric cancer and to analyze their clinical signifi cance. METHODS: Immunohistochemistry was used to investigate the expression of COX-2 and GCS in 63 cases of gastric cancer tissues and 30 cases of non-gastric cancer tissues. The correlation of COX-2 and GCS expression with patient's age, sex, tumor histological type, differentiation, and lymph node metastasis was analyzed. RESULTS: The positive rate of COX-2 expres-sion in gastric cancer was higher than that in non-cancerous tissue (87.3% vs 36.7%, P < 0.05). The positive rate of GCS expression in gastric cancer was also higher than that in non-cancerous tissue (49.2% vs 23.3%, P < 0.05). Neither COX-2 nor GCS expression was related with age, sex, tumor differentiation, depth of invasion or histological type (all P > 0.05). The positive rate of COX-2 in patients with lymph node metastasis was significantly higher than that in patients without lymph node metastasis (100% vs 69.2%, P < 0.05), whereas the positive rate of GST-π was not related with lymph node metastasis (P > 0.05). There is a signifi cant correlation between the expression of COX-2 and that of GST-π in gastric cancer (r = 0.724, P = 0.004). CONCLUSION: GCS is highly expressed in gastric cancer and may be involved in tumor drug resistance. COX-2 may mediate drug resistance by influencing the expression of GCS in gastric cancer.
What problem does this paper attempt to address?